Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.
about
5-HT3 receptorsThe 5-HT3 receptor as a therapeutic targetPharmacodynamics of memantine: an update.Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors.5-HT₃ antagonists under development.Allosteric modulation of the 5-HT(3) receptor.The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptors.Are 5-HT3 antagonists effective in obsessive-compulsive disorder? A systematic review of literature.Clozapine-induced acute gastrointestinal necrosis: a case report.Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants.Lack of association of the 5-HT(3A) receptor with schizophrenia.Lipid raft integrity affects GABAA receptor, but not NMDA receptor modulation by psychopharmacological compounds.The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release.Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses.
P2860
Q24648000-438A536C-16B9-4F3E-A8DF-E68F8D344473Q24681066-0C2B0247-4E05-4F42-B193-89A0DA8AB3D4Q30490604-4BAB1FD9-1F73-4AAA-932C-CD3ABC9BBD00Q30493133-00F36D05-C358-481D-A5BF-067964FD46C2Q33495575-53CBA8FC-6764-4BC2-8B5A-B642783B39A5Q33719742-3C859AF4-DE69-49FE-8D75-07D416CBA44FQ34770513-C7BCB020-FACA-4DC4-9D6C-83DA3359E816Q36013753-F3DF1E8A-7BDB-4301-8809-B6860EA2D4D1Q38353212-2CCD1D2A-1F7C-4AAB-A1A3-118ABE0523A5Q42362955-B2A72AA9-F8DC-4225-B367-2C3B0B16B52FQ42592784-6BF71403-1261-48BB-9456-BCFD8DB2572BQ42682344-1BB320B1-B21D-43C0-BBE2-C24C02897F27Q43852892-0D54D4F8-A164-4155-8320-BBD730F3D792Q44089581-D00B2B84-DD64-4062-ACA7-85D249949CE1Q46082663-5B0741B8-BA43-4770-A837-EC955AE69DD4Q47211764-0A9C570B-3633-406E-987B-3ACECBBFCEEAQ48388044-D43F40AC-107C-4F78-B6A6-BA10C352C8A4
P2860
Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antipsychotic drugs antagonize ...... ts in a noncompetitive manner.
@en
type
label
Antipsychotic drugs antagonize ...... ts in a noncompetitive manner.
@en
prefLabel
Antipsychotic drugs antagonize ...... ts in a noncompetitive manner.
@en
P2093
P2860
P356
P1433
P1476
Antipsychotic drugs antagonize ...... nts in a noncompetitive manner
@en
P2093
Eisensamer B
Hapfelmeier G
Holsboer F
Rupprecht R
P2860
P2888
P304
846-58, 818
P356
10.1038/SJ.MP.4001490
P407
P577
2004-09-01T00:00:00Z